Cited by 407Cancer Immunotherapy and BiomarkersCancer, Hypoxia, and MetabolismT-cell and B-cell Immunology

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Open access

Zhao, Ende, Maj, Tomasz, Kryczek, Ilona, Li, Wei, Wu, Ke, Zhao, Lili, Wei, Shuang, Crespo, Joel, Wan, Shanshan, Vatan, Linda, Szeliga, Wojciech, Shao, Irene, Wang, Yin, Liu, Yan, Varambally, Sooryanarayana, Chinnaiyan, Arul M, Welling, Theodore H, Marquez, Victor, Kotarski, Jan, Wang, Hongbo, Wang, Zehua, Zhang, Yi, Liu, Rebecca, Wang, Guobin, Zou, Weiping·2016·Nature Immunology

DOI 10.1038/ni.3313PMC PMC4684796

Open this paper in CoChat — free account

Abstract

Aerobic glycolysis regulates T cell function. However, whether and how primary cancer alters T cell glycolytic metabolism and affects tumor immunity in cancer patients remains a question. Here we found that ovarian cancers imposed glucose restriction on T cells and dampened their function via maintaining high expression of microRNAs miR-101 and miR-26a, which constrained expression of the methyltransferase EZH2. EZH2 activated the Notch pathway by suppressing Notch repressors Numb and Fbxw7 via trimethylation of histone H3 at Lys27 and, consequently, stimulated T cell polyfunctional cytokine expression and promoted their survival via Bcl-2 signaling. Moreover, small hairpin RNA-mediated knockdown of human EZH2 in T cells elicited poor antitumor immunity. EZH2(+)CD8(+) T cells were associated with improved survival in patients. Together, these data unveil a metabolic target and mechanism of cancer immune evasion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/ni.3313

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Self-citation
T cell exhaustion
Wherry, E. J. (2011) · Nature Immunology · doi:10.1038/ni.2035 · Cited by 4,062
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Self-citation
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Self-citation
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135

Flagged first, then by citations

Show all 50 references

Sorted by citations

Items 101–200 of 407

SENP7 senses oxidative stress to sustain metabolic fitness and antitumor functions of CD8+ T cells
Wu, Z., Huang, H., Han, Q., Hu, Z., Teng, X.-L., Ding, R., Ye, Y., Yu, X., Zhao, R., Wang, Z., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155224 · Cited by 84
Self-citation
Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
Zhao, J., Jin, D., Huang, M., Ji, J., Xu, X., Wang, F., Zhou, L., Bao, B., Jiang, F., Xu, W., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1416472 · Cited by 84
Noncoding RNAs link metabolic reprogramming to immune microenvironment in cancers
Zhang, Y., Mao, Q., Xia, Q., Cheng, J., Huang, Z., Li, Y., Chen, P., Yang, J., Fan, X., Liang, Y., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01179-y · Cited by 81
Self-citation
Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment
Zhou, L., & Yu, D. C. W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107205 · Cited by 96
Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance
Sierra, R. A., Trillo-Tinoco, J., Mohamed, E. T., Yu, L. C., Achyut, B. R., Arbab, A. S., Bradford, J. W., Osborne, B. A., Miele, L., & Rodrı́guez, P. C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0357 · Cited by 82
Metabolic Adaptation of Human CD4+ and CD8+ T-Cells to T-Cell Receptor-Mediated Stimulation
Jones, N., Cronin, J., Dolton, G. M., Panetti, S., Schauenburg, A. J. A., Galloway, S. A. E., Sewell, A. K., Cole, D. K., Thornton, C. A., & Francis, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01516 · Cited by 81
EZH2 promotes hepatocellular carcinoma progression through modulating miR-22/galectin-9 axis
Chen, S., Pu, J., Bai, J., Yin, Y., Wu, K., Wang, J., Shuai, X., Gao, J., Tao, K., Wang, G., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0670-6 · Cited by 83
Self-citation
Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects
Xu, S., Xu, Y., Yin, M., Zhang, S., Liu, P., Koroleva, M., Si, S., Little, P. J., Pelisek, J., & Jin, Z. G. (2018) · Theranostics · doi:10.7150/thno.21966 · Cited by 82
Immune Cell Population in Ovarian Tumor Microenvironment
Cai, D. L., & Jin, L. (2017) · Journal of Cancer · doi:10.7150/jca.20314 · Cited by 80
EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy
Sun, S., Feng, Y., Xu, D., Zheng, H., & Li, M. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188700 · Cited by 81
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
Lotze, M. T., Olejniczak, S. H., & Skokos, D. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01061-1 · Cited by 86
Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
Li, T., Yu, C., & Zhuang, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.640700 · Cited by 75
HIF: a master regulator of nutrient availability and metabolic cross‐talk in the tumor microenvironment
Missiaen, R., Lesner, N. P., & Simon, M. C. (2023) · The EMBO Journal · doi:10.15252/embj.2022112067 · Cited by 78
Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization
Chen, M., Xiao, C., Lao, X., Yuan, W., Liu, R., Zeng, Q., Wang, J., Ouyang, F., Chen, D., Chan, K., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0329 · Cited by 74
Self-citation
Polycomb repressive complex’s evolutionary conserved function: the role of EZH2 status and cellular background
Gall‐Tros̆elj, K., Kujundžić, R. N., & Ugarkovic, D. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0226-1 · Cited by 73
Structure of the PRC2 complex and application to drug discovery
Shi, Y., Wang, X., Zhuang, Y., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.7 · Cited by 75
Alteration of Tumor Metabolism by CD4+ T Cells Leads to TNF-α-Dependent Intensification of Oxidative Stress and Tumor Cell Death
Habtetsion, T. G., Ding, Z., Pi, W., Li, T., Lu, C., Chen, T., Xi, C., Spartz, H., Liu, K., Hao, Z., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.012 · Cited by 72
Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment
Hua, Y., Yang, S., Zhang, Y., Li, J., Wang, M., Yeerkenbieke, P., Liao, Q., & Liu, Q. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02925-5 · Cited by 74
Self-citation
T Cell Exhaustion and CAR‐T Immunotherapy in Hematological Malignancies
Tang, L., Zhang, Y., Hu, Y., & Mei, H. (2021) · BioMed Research International · doi:10.1155/2021/6616391 · Cited by 72
Self-citation
Antitumor T-cell Reconditioning: Improving Metabolic Fitness for Optimal Cancer Immunotherapy
Rivadeneira, D. B., & Delgoffe, G. M. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0894 · Cited by 69
Epigenetic Variability in Systemic Lupus Erythematosus: What We Learned from Genome-Wide DNA Methylation Studies
Teruel, M., & Sawalha, A. H. (2017) · Current Rheumatology Reports · doi:10.1007/s11926-017-0657-5 · Cited by 65
EZH2 Modulates the DNA Methylome and Controls T Cell Adhesion Through Junctional Adhesion Molecule A in Lupus Patients
Tsou, P., Coit, P., Kilian, N. C., & Sawalha, A. H. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40338 · Cited by 64
Inhibition of EZH2 Ameliorates Lupus‐Like Disease in MRL/ lpr Mice
Rohraff, D. M., He, Y., Farkash, E. A., Schonfeld, M., Tsou, P., & Sawalha, A. H. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40931 · Cited by 63
Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression
Yu, C., Xiong, C., Tang, J., Hou, X., Liu, N., Bayliss, G. P., & Zhuang, S. (2021) · Theranostics · doi:10.7150/thno.48679 · Cited by 64
Carbonic anhydrase XII mediates the survival and prometastatic functions of macrophages in human hepatocellular carcinoma
Ning, W.-R., Jiang, D., Liu, X.-C., Huang, Y.-F., Peng, Z.-P., Jiang, Z.-Z., Kang, T., Zhuang, S.-M., Wu, Y., & Zheng, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153110 · Cited by 66
Tumor metabolism regulating chemosensitivity in ovarian cancer
Han, C. Y., Patten, D. A., Richardson, R. B., Harper, M., & Tsang, B. K. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.176 · Cited by 62
METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma
Wu, Y., Chang, N., Zhang, Y., Zhang, X., Xu, L., Che, Y., Qiao, T., Wu, B., Zhou, Y., Jiang, J., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01880-3 · Cited by 62
Self-citation
Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
Christofides, A., Karantanos, T., Bardhan, K., & Boussiotis, V. A. (2016) · Oncotarget · doi:10.18632/oncotarget.12928 · Cited by 61
Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer
Liu, Z., Zhu, W., Kong, X., Chen, X., Sun, X., Zhang, W., & Zhang, R. (2019) · Oncology Reports · doi:10.3892/or.2019.7294 · Cited by 60
Nano-immunotherapy for each stage of cancer cellular immunity: which, why, and what?
Zuo, S., Song, J., Zhang, J., He, Z., Sun, B., & Sun, J. (2021) · Theranostics · doi:10.7150/thno.59953 · Cited by 56
Immunometabolism and PI(3)K Signaling As a Link between IL-2, Foxp3 Expression, and Suppressor Function in Regulatory T Cells
Fan, M. Y., & Turka, L. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00069 · Cited by 57
Leveraging epigenetics to enhance the efficacy of immunotherapy
Licht, J. D., & Bennett, R. L. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01100-x · Cited by 54
Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8+ T Cells
Chowdhury, S., Kar, A., Bhowmik, D., Gautam, A., Basak, D., Sarkar, I., Ghosh, P., Sarkar, D., Deka, A., Chakraborty, P., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-4052 · Cited by 58
RETRACTED: EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells
Zheng, M. H., Cao, M., Luo, X., Li, L., Wang, K., Wang, S., Wang, H., Tang, Y., Tang, Y., & Liang, X. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14579 · Cited by 55
Self-citation
Retracted
Therapeutic Cancer Vaccines—T Cell Responses and Epigenetic Modulation
Kartikasari, A. E. R., Prakash, M. D., Cox, M., Wilson, K., Boer, J. C., Cauchi, J. A., & Plebanski, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03109 · Cited by 54
Enhanced glucose metabolism mediated by CD147 contributes to immunosuppression in hepatocellular carcinoma
Li, X., Zhang, Y., Ma, W., Fu, Q., Liu, J., Yin, G., Chen, P., Dai, D., Chen, W., Qi, L., et al. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02457-y · Cited by 59
Self-citation
An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response
Dong, H., Liu, S., Zhang, X., Chen, S., Kang, L., Chen, Y., Ma, S., Fu, X., Liu, Y., Zhang, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0428 · Cited by 53
Self-citation
Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
Leone, R. D., & Powell, J. D. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0791 · Cited by 53
Control of T Cell Metabolism by Cytokines and Hormones
Bishop, E. L., Gudgeon, N. H., & Dimeloe, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653605 · Cited by 56
Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications
Desaulniers, D. M., Vasseur, P., Jacobs, A. C., Aguila, M. C., Ertych, N., & Jacobs, M. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010969 · Cited by 55
Research progress on the mechanism of glycolysis in ovarian cancer
Li, C., Liu, F.-Y., Shen, Y., Tian, Y., & Han, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1284853 · Cited by 57
Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
Ping, S., Wang, S., Zhao, Y., He, J., Li, G., Li, D., Wei, Z., & Chen, J. (2022) · Cancer Medicine · doi:10.1002/cam4.4706 · Cited by 51
Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy
Tuccitto, A., Shahaj, E., Vergani, E., Ferro, S., Huber, V., Rodolfo, M., Castelli, C., Rivoltini, L., & Vallacchi, V. (2018) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-018-2477-z · Cited by 54
Immunometabolism: Insights from the Drosophila model
Galenza, A., & Foley, E. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.01.011 · Cited by 52
Metabolic regulation of epigenetic remodeling in immune cells
Britt, E. C., John, S. V., Locasale, J. W., & Fan, J. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.008 · Cited by 54
Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications
Wang, X., Luo, X., Xiao, R., Liu, X., Zhou, F., Jiang, D., Bai, J., Cui, M., You, L., & Yupei, Z. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02334-4 · Cited by 59
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 56
Methionine Commits Cells to Differentiate Into Plasmablasts Through Epigenetic Regulation of BTB and CNC Homolog 2 by the Methyltransferase EZH 2
Zhang, M., Iwata, S., Hajime, M., Ohkubo, N., Todoroki, Y., Miyata, H., Ueno, M., He, H., Zhang, T., Fan, J., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41208 · Cited by 49
Extracellular vesicles derived from M2-polarized tumor-associated macrophages promote immune escape in ovarian cancer through NEAT1/miR-101-3p/ZEB1/PD-L1 axis
Yin, L., & Wang, Y. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03305-2 · Cited by 48
Self-citation
Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
Tien, F., Lu, H., Lin, S., & Tsai, H.-C. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-022-00893-0 · Cited by 51
miRNAs, Melanoma and Microenvironment: An Intricate Network
Romano, G., & Kwong, L. N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112354 · Cited by 49
EZH2 as a Regulator of CD8+ T Cell Fate and Function
Stairiker, C. J., Thomas, G. D., & Salek‐Ardakani, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593203 · Cited by 49
Immunometabolism in the Tumor Microenvironment
Roy, D. G., Kaymak, I., Williams, K. S., Ma, E. H., & Jones, R. G. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055817 · Cited by 49
KLRG1 restricts memory T cell antitumor immunity
Li, L., Wan, S., Tao, K., Wang, G., & Zhao, E. (2016) · Oncotarget · doi:10.18632/oncotarget.11430 · Cited by 52
Self-citation
MicroRNA‑34a inhibits liver cancer cell growth by reprogramming glucose metabolism
Zhang, H., Wang, Y., & Han, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8399 · Cited by 48
Self-citation
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
Macpherson, A. M., Barry, S. C., Ricciardelli, C., & Oehler, M. K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092967 · Cited by 51
The epigenetic hallmarks of immune cells in cancer
Yu, J. H., Xiao, C., Fan, T. T., Deng, Z., Wang, D., Cai, W., Li, J., Liao, T., Li, C., & He, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02255-4 · Cited by 52
MicroRNA-491 regulates the proliferation and apoptosis of CD8+ T cells
Yu, T., Zuo, Q., Gong, L., Wang, L., Zou, Q., & Xiao, B. (2016) · Scientific Reports · doi:10.1038/srep30923 · Cited by 46
Transcriptional and epigenetic regulation of T cell hyporesponsiveness
Pereira, R. M., Hogan, P. G., Rao, A., & Martínez, G. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ri0317-097r · Cited by 50
EHBP1L1 Drives Immune Evasion in Renal Cell Carcinoma through Binding and Stabilizing JAK1
Pan, Y., Shu, G., Fu, L., Huang, K., Zhou, X., Gui, C., Liu, H., Jin, X., Chen, M., Li, P., et al. (2023) · Advanced Science · doi:10.1002/advs.202206792 · Cited by 47
Self-citation
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis
Wu, F., Xu, L., Tu, Y., Cheung, O. K.-W., Szeto, L. L. M., Mok, M. T. S., Yang, W., Kang, W., Cao, Q., Lai, P. B. S., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.039 · Cited by 45
T lymphocyte cell: A pivotal player in lung cancer
Wu, Y., Yuan, M., Wang, C., Chen, Y., Zhang, Y., & Zhang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1102778 · Cited by 48
Self-citation
Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL
Wu, C.-Y., Huang, C.-X., Lao, X., Zhou, Z.-W., Jian, J.-H., Li, Z., Wu, Y., Liu, Z., Chen, L., Liu, L., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.027 · Cited by 44
Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism
Beltrán‐Anaya, F. O., Cedro‐Tanda, A., Hidalgo‐Miranda, A., & Romero-Cordoba, S. L. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00342 · Cited by 44
Systematic Proteome and Lysine Succinylome Analysis Reveals Enhanced Cell Migration by Hyposuccinylation in Esophageal Squamous Cell Carcinoma
Guo, Z., Pan, F., Peng, L., Tian, S., Jiao, J., Liao, L., Lu, C., Zhai, G., Wu, Z., Dong, H., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002150 · Cited by 45
The diverse roles of the circadian clock in cancer
Fortin, B. M., Mahieu, A. L., Fellows, R. C., Kang, Y., Lewis, A. N., Ead, A., Lamia, K. A., Cao, Y., Pannunzio, N. R., & Masri, S. (2025) · Nature Cancer · doi:10.1038/s43018-025-00981-8 · Cited by 49
Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies
Ma, G., Li, C., Zhang, Z., Liang, Y., Liang, Z., Chen, Y., Wang, L., Li, D., Zeng, M., Shan, W., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.697894 · Cited by 45
Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer
Wu, Y., Deng, Y., Zhu, J. W., Duan, Y., Weng, W., & Wu, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s180520 · Cited by 42
Immune modulatory functions of EZH2 in the tumor microenvironment: implications in cancer immunotherapy.
Wang, X., Brea, L. T., & Yu, J. (2019) · PubMed Central · Cited by 43
Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
Chen, C., Wang, Z., Ding, Y., & Qin, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1090429 · Cited by 43
Self-citation
PABPC1L Induces IDO1 to Promote Tryptophan Metabolism and Immune Suppression in Renal Cell Carcinoma
Shu, G., Chen, M., Liao, W., Fu, L., Lin, M., Gui, C., Cen, J., Lu, J. K., Chen, Z., Wei, J., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2521 · Cited by 43
Self-citation
Metabolic rewiring and communication in cancer immunity
Chapman, N. M., & Chi, H. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.02.001 · Cited by 44
Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy
Hirukawa, A., Singh, S., Wang, J. H., Rennhack, J. P., Swiatnicki, M., Sanguin‐Gendreau, V., Zuo, D., Daldoul, K., Lavoie, C. A., Park, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.105 · Cited by 43
Epigenetics and CD8+ T cell memory*
Montacchiesi, G., & Pace, L. (2021) · Immunological Reviews · doi:10.1111/imr.13057 · Cited by 43
Metabolic advantages of regulatory T cells dictated by cancer cells
Kondo, M., Kumagai, S., & Nishikawa, H. (2023) · International Immunology · doi:10.1093/intimm/dxad035 · Cited by 42
How metabolism bridles cytotoxic CD8+ T cells through epigenetic modifications
Acker, H. H. V., Ma, S., Scolaro, T., Kaech, S. M., & Mazzone, M. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.03.006 · Cited by 39
Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion
Song, B.-S., Moon, J. S., Tian, J., Lee, H. Y., Sim, B. C., Kim, S., Kang, S., Kim, J. T., Nga, H. T., Benfeitas, R., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004337 · Cited by 43
Intimate communications within the tumor microenvironment: stromal factors function as an orchestra
Cheng, B., Yu, Q., & Wang, W. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-022-00894-z · Cited by 43
Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism
Rosa, V. D., Rella, F. D., Giacomo, A. D., & Matarese, G. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.001 · Cited by 38
Metabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
Gong, Y., Yang, J., Wang, Y., Xue, L., & Wang, J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32990 · Cited by 40
Self-citation
Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients
Zhaoyun, L., & Fu, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663748 · Cited by 38
Metabolic reprogramming of the tumor immune microenvironment in ovarian cancer: A novel orientation for immunotherapy
Lin, Y., Zhou, X., Ni, Y., Zhao, X., & Liang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1030831 · Cited by 38
Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development
Cheng, Y., Li, G., Wang, W., Sun, Y., Zhang, Y., Chen, Z., Stovall, D. B., Li, D., Shi, J., & Sui, G. (2021) · Cancers · doi:10.3390/cancers13102402 · Cited by 37
Self-citation
Epigenetic mechanisms of tumor resistance to immunotherapy
Arenas-Ramirez, N., Sahin, D., & Boyman, O. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2908-7 · Cited by 36
FBXW7 in breast cancer: mechanism of action and therapeutic potential
Chen, S., Leng, P., Guo, J., & Zhou, H. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02767-1 · Cited by 36
Metabolic Reprogramming of Glycolysis, Lipids, and Amino Acids in Tumors: Impact on CD8 + T Cell Function and Targeted Therapeutic Strategies
Liang, P., Li, Z., Chen, Z., Chen, Z., Jin, T., He, F., Chen, X., Gou, H., & Yang, K. (2025) · The FASEB Journal · doi:10.1096/fj.202403019r · Cited by 42
Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection
Hart, P. J., Copland, A., Diogo, G. R., Harris, S., Spallek, R., Oehlmann, W., Singh, M., Basile, J. I., Rottenberg, M. E., Paul, M. J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.016 · Cited by 39
E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness
Cheng, F. H. C., Lin, H., Hwang, T., Chen, Y.-C., Huang, R., Chang, C.-B., Yang, W., Lin, R., Lin, C., Chen, G. C. W., et al. (2018) · Cancer Science · doi:10.1111/cas.13920 · Cited by 35
Metabolism and Autoimmune Responses: The microRNA Connection
Colamatteo, A., Micillo, T., Bruzzaniti, S., Fusco, C., Garavelli, S., Rosa, V. D., Galgani, M., Spagnuolo, M. I., Rella, F. D., Puca, A. A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01969 · Cited by 38
Epigenetic modulation of immunotherapy and implications in head and neck cancer
Zhou, L., Xu, N., Shibata, H., Saloura, V., & Uppaluri, R. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09944-0 · Cited by 36
The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy
Wong, W., Yin, B., Lam, C. Y. K., Huang, Y., Yan, J., Tan, Z., & Wong, S. H. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.783227 · Cited by 35
FBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
Shen, W., Zhou, Q., Peng, C., Li, J., Yuan, Q., Zhu, H., Zhao, M., Jiang, X., Liu, W., & Ren, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.880077 · Cited by 40
Deoxyribonucleic Acid Methylation in Systemic Lupus Erythematosus: Implications for Future Clinical Practice
Weeding, E., & Sawalha, A. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00875 · Cited by 34
Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer
Yu, J., Liu, T., Liang, L., Liu, J., Cai, H., Zeng, J., Wang, T., Li, J., Xiu, L., Li, N., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02045-0 · Cited by 34
Easy or Not—The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity
Huang, J., Zhang, J., Guo, Z., Li, C., Tan, Z. W., Wang, J., Yang, J., & Xue, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741302 · Cited by 33
A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer
McAllister, M. J., Underwood, M. A., Leung, H. Y., & Edwards, J. (2018) · Translational research · doi:10.1016/j.trsl.2018.11.004 · Cited by 33
Heterogeneity of Glucose Transport in Lung Cancer
Martinez, C. A., & Scafoglio, C. (2020) · Biomolecules · doi:10.3390/biom10060868 · Cited by 35
Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion
Koss, B. S., Shields, B. D., Taylor, E. M., Storey, A. J., Byrum, S. D., Gies, A. J., Washam, C. L., Choudhury, S. R., Ahn, J. H., Uryu, H., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0524 · Cited by 33
Self-citation
LINC00152 mediates CD8+ T-cell infiltration in gastric cancer through binding to EZH2 and regulating the CXCL9, 10/CXCR3 axis
Ou, J., Lei, P., Yang, Z., Yang, M. G., Luo, L.-M., Mo, H., Luo, G., & He, J. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-021-09967-z · Cited by 33
Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy
Hou, Y., Žák, J., Shi, Y., Pratumchai, I., Dinner, B., Wang, W., Qin, K., Weber, E. W., Teijaro, J. R., & Wu, P. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0089 · Cited by 33

Authors: Zhao, E., Maj, T., Kryczek, I., Li, W., Wu, K., Zhao, L., Wei, S., Crespo, J., Wan, S., Vatan, L., Szeliga, W., Shao, I., Wang, Y., Liu, Y., Varambally, S., Chinnaiyan, A. M., Welling, T. H., Marquez, V., Kotarski, J., Wang, H., Wang, Z., Zhang, Y., Liu, R., Wang, G., & Zou, W.
Affiliations: University of Michigan (US)
Medical University of Lublin (PL)
Wuhan Union Hospital (CN)
Corresponding author: Wang, Guobin
Zou, Weiping
ORCID: Zhao, Ende
Maj, Tomasz
Kryczek, Ilona
Li, Wei
Wu, Ke
Zhao, Lili
Wei, Shuang
Crespo, Joel
Wan, Shanshan
Vatan, Linda
Szeliga, Wojciech
Liu, Yan
Varambally, Sooryanarayana
Chinnaiyan, Arul M
Kotarski, Jan
Wang, Hongbo
Wang, Zehua
Liu, Rebecca
Wang, Guobin
Zou, Weiping
Venue: Nature Immunology
Publisher: Springer Science and Business Media LLC
Published: 2015-11-02
Volume: 17
Issue: 1
Pages: 95-103
ISSN: 1529-2908 (ISSN-L)
1529-2916
DOI: 10.1038/ni.3313
PMC: PMC4684796
OpenAlex: W2202401513
Cited by: 405
References: 50
Citations by year: 2026: 19 · 2025: 30 · 2024: 37 · 2023: 35 · 2022: 54 · 2021: 51 · 2020: 42 · 2019: 34 · 2018: 38 · 2017: 35 · 2016: 29 · 2015: 1
FWCI: 15.00
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Heart, Lung, and Blood Institute (R01HL127351)
National Cancer Institute (R01CA092562, CA099985, R01CA123088, R01CA152470, R01CA156685, R01CA172106, CA123088, 5P30 CA 46592, CA156685, R01CA171306, R01CA193136, CA171306, R01CA099985, R01CA190176, P30CA046592)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords: tumor immune evasion, EZH2, microRNA, miR-101, miR-26a, glycolysis, glucose restriction, Notch signaling, H3K27me3, Numb, FBXW7, T cell apoptosis, ovarian cancer, antitumor immunity, CD8+ T cells
MeSH terms: Enhancer of Zeste Homolog 2 Protein, Animals, Cell Separation, Female, Flow Cytometry, Fluorescent Antibody Technique, Glycolysis, Humans, Melanoma, Experimental, Mice, Inbred C57BL, Neoplasms, Ovarian Neoplasms, T-Lymphocytes, Transfection, Immunoblotting, Gene Expression Regulation, Neoplastic, Tumor Escape, MicroRNAs, Tissue Array Analysis, Chromatin Immunoprecipitation, Real-Time Polymerase Chain Reaction, Polycomb Repressive Complex 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks